V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016087 | 270008494 | 1.76 | 99.4 | null | 2016-04-05 | 2016-10-30 | Cetuximab 7 day (>Cycle 2) | N | N | 270012948 | CETUXIMAB |
| 270016088 | 270008496 | 1.6 | 82.25 | Curative (C) | null | 2015-03-20 | Escalated BEACOPP | 2 | N | 270012949 | BEACOPP |
| 270016089 | 270008497 | 1.78 | 68 | Curative (C) | 2016-03-14 | 2016-03-15 | HD EuroNet-PHL-C1 COPDAC | 01 | null | 270012949 | TRIAL |
| 270016090 | 270008498 | 1.64 | null | Curative (C) | 2015-02-12 | 2015-02-15 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012954 | TRIAL |
| 270016091 | 270008499 | null | 76.6 | Curative (C) | 2014-04-18 | 2015-04-04 | CETUXIMAB | N | N | 270012955 | CETUXIMAB |
| 270016092 | 270008501 | 1.58 | null | Curative (C) | 2014-08-19 | 2014-08-19 | BEACOPP-14 | 02 | N | 270012961 | BEACOPP |
| 270016093 | 270016682 | 1.87 | 61.7 | Curative (C) | 2017-10-31 | 2017-12-01 | Trial Unspecified | N | N | 270012966 | TRIAL |
| 270016094 | 270008502 | 0 | 70.4 | Curative (C) | 2014-10-01 | 2014-10-20 | COPP + Dacarbazine | N | N | 270012975 | COPP + DACARBAZINE |
| 270016095 | 270014025 | null | 71 | Curative (C) | 2016-08-01 | 2016-08-10 | Escalated BEACOPP | 02 | N | 270012985 | BEACOPP |
| 270016096 | 270014025 | 1.88 | 72.6 | Neo-adjuvant (N) | null | 2017-12-05 | COPP + Dacarbazine | 02 | N | 270012985 | COPP + DACARBAZINE |
| 270016097 | 270008509 | 1.63 | null | Curative (C) | 2017-05-29 | 2017-06-19 | BEACOPP-14 | N | N | 270012995 | BEACOPP |
| 270016098 | 270008509 | 1.58 | null | Curative (C) | null | 2014-02-17 | Escalated BEACOPP | N | N | 270012995 | BEACOPP |
| 270016099 | 270008510 | 1.43 | 61.2 | Palliative (P) | 2013-12-31 | 2014-03-05 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013005 | TRIAL |
| 270016100 | 270008510 | 1.65 | 37.7 | Curative (C) | 2014-08-15 | 2014-10-13 | COPP + Dacarbazine | N | null | 270013005 | COPP + DACARBAZINE |
| 270016101 | 270008511 | 1.73 | 70.2 | Curative (C) | null | 2015-08-31 | BEACOPP | Y | N | 270013017 | BEACOPP |
| 270016102 | 270014029 | 1.71 | 65.25 | Curative (C) | 2018-11-11 | 2018-12-07 | Trial Unspecified | 01 | N | 270013022 | TRIAL |
| 270016103 | 270008515 | 1.88 | null | Neo-adjuvant (N) | 2017-05-16 | 2017-06-13 | COPP + Dacarbazine | N | N | 270013023 | COPP + DACARBAZINE |
| 270016104 | 270014030 | null | 38.2 | Not known (9) | 2017-11-08 | 2017-11-16 | BEACOPP-14 | 02 | N | 270013028 | BEACOPP |
| 270016105 | 270008517 | 1.75 | 55.2 | Curative (C) | 2017-10-14 | 2018-01-31 | BEACOPP | N | N | 270013029 | BEACOPP |
| 270016106 | 270008521 | 0 | null | Curative (C) | 2015-07-24 | 2015-07-25 | COPP + Dacarbazine | null | null | 270013048 | COPP + DACARBAZINE |
| 270016107 | 270008523 | null | 43.7 | Curative (C) | 2014-09-08 | 2014-09-15 | HD EuroNet-PHL-C1 COPDAC | 1 | null | 270013072 | TRIAL |
| 270016108 | 270008523 | 0 | 40.6 | Palliative (P) | 2016-07-24 | 2016-07-24 | Trial Unspecified | Y | N | 270013072 | TRIAL |
| 270016109 | 270008525 | 1.82 | 61.7 | Curative (C) | 2018-05-11 | 2018-07-18 | Trial Unspecified | Y | N | 270013096 | TRIAL |
| 270016110 | 270008529 | 1.75 | 59.9 | Disease modification (D) | 2012-05-31 | 2013-12-03 | Trial Unspecified | Y | N | 270013128 | TRIAL |
| 270016112 | 270008534 | 1.85 | 42.7 | Palliative (P) | 2014-01-09 | 2014-01-10 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013143 | TRIAL |
| 270016113 | 270008537 | 1.51 | 78.9 | Curative (C) | 2015-02-28 | 2015-03-15 | Cetuximab 7 day (>Cycle 2) | N | null | 270013145 | CETUXIMAB |
| 270016114 | 270008538 | 1.79 | 88 | Curative (C) | null | 2017-05-05 | BEACOPP | N | null | 270013148 | BEACOPP |
| 270016115 | 270008540 | 1.6 | 45.4 | Disease modification (D) | 2015-08-21 | 2016-05-14 | Cetuximab 14 day | 2 | null | 270013162 | CETUXIMAB |
| 270016116 | 270008543 | 0 | 15.3 | Neo-adjuvant (N) | 2013-12-31 | 2014-03-05 | COPP + Dacarbazine | N | null | 270013164 | COPP + DACARBAZINE |
| 270016117 | 270016693 | 0 | null | Adjuvant (A) | 2013-11-18 | 2013-12-16 | COPP + Dacarbazine | N | N | 270013165 | COPP + DACARBAZINE |
| 270016118 | 270008544 | null | null | Adjuvant (A) | 2013-09-05 | 2013-09-09 | COPP + Dacarbazine | 02 | N | 270013188 | COPP + DACARBAZINE |
| 270016119 | 270008547 | 1.59 | 40.4 | Palliative (P) | 2014-06-17 | 2017-01-24 | Cetuximab 14 day | N | N | 270013196 | CETUXIMAB |
| 270016120 | 270008552 | 1.68 | null | Palliative (P) | 2017-11-12 | 2017-11-15 | Cetuximab 7 day (Cycle 1) | N | Y | 270013210 | CETUXIMAB |
| 270016121 | 270019108 | 1.76 | null | null | 2015-08-12 | 2015-08-19 | COPP + Dacarbazine | 02 | N | 270013221 | COPP + DACARBAZINE |
| 270016122 | 270008556 | 1.55 | 60 | Neo-adjuvant (N) | 2013-01-08 | 2013-04-24 | COPP + Dacarbazine | N | null | 270013224 | COPP + DACARBAZINE |
| 270016123 | 270008559 | 1.62 | 35 | Palliative (P) | 2015-09-27 | 2016-11-19 | CETUXIMAB | 2 | N | 270013228 | CETUXIMAB |
| 270016124 | 270008562 | 0 | 68.7 | null | 2016-10-11 | 2016-12-08 | COPP + Dacarbazine | 02 | N | 270013246 | COPP + DACARBAZINE |
| 270016125 | 270008565 | 0 | 70.5 | Curative (C) | 2018-06-10 | 2018-06-11 | COPP + Dacarbazine | 2 | N | 270013267 | COPP + DACARBAZINE |
| 270016126 | 270008567 | 1.76 | 53.5 | Curative (C) | 2017-07-17 | 2017-07-22 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013279 | TRIAL |
| 270016127 | 270014051 | 1.63 | 90.2 | Curative (C) | 2018-03-16 | 2018-03-23 | Cetuximab 14 day | 02 | N | 270013285 | CETUXIMAB |
| 270016128 | 270008575 | 1.72 | 16.4 | Curative (C) | 2016-10-24 | 2016-11-15 | Cetuximab 7 day (>Cycle 2) | 99 | null | 270013318 | CETUXIMAB |
| 270016129 | 270008576 | 1.86 | 92.3 | Curative (C) | 2013-09-29 | 2014-04-18 | Cetuximab 14 day | 2 | N | 270013336 | CETUXIMAB |
| 270016130 | 270008579 | 0 | 40.4 | Curative (C) | 2016-06-18 | 2016-08-17 | COPP + Dacarbazine | null | N | 270013349 | COPP + DACARBAZINE |
| 270016131 | 270008582 | 1.7 | 50.9 | Curative (C) | 2013-10-09 | 2013-11-08 | Cetuximab 14 day | N | N | 270013353 | CETUXIMAB |
| 270016132 | 270008584 | null | 74.3 | Curative (C) | 2014-08-25 | 2014-08-28 | Escalated BEACOPP | N | N | 270013366 | BEACOPP |
| 270016133 | 270008586 | 1.72 | 61.2 | Curative (C) | 2017-09-18 | 2017-10-23 | CETUXIMAB | N | N | 270013367 | CETUXIMAB |
| 270016134 | 270008588 | null | null | Palliative (P) | 2014-06-18 | 2015-07-12 | Trial Unspecified | N | null | 270013382 | TRIAL |
| 270016135 | 270008590 | 1.5 | 97.3 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-02 | COPP + Dacarbazine | 02 | N | 270013383 | COPP + DACARBAZINE |
| 270016136 | 270008592 | 1.56 | 45.1 | Curative (C) | 2014-11-29 | 2014-12-15 | COPP + Dacarbazine | N | null | 270013387 | COPP + DACARBAZINE |
| 270016137 | 270008598 | 1.76 | 66.8 | Curative (C) | 2016-08-03 | 2016-08-07 | CETUXIMAB | N | N | 270013405 | CETUXIMAB |